This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Governments & Organizations » United States

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Health Reform: A Year-by-Year Rundown of What Happens and When

Posted: Tuesday, March 23, 2010

The historic health overhaul that President Obama signed on Tuesday (in advance of further "fixes" in a reconciliation bill) will make sweeping changes in our health system. They include new consumer protections, expanded coverage of the uninsured, penalties for people and businesses who don't buy insurance, attempts to control rising costs, and Medicare savings and new taxes to pay for it all. Here is a year-by-year look at what's in store, assuming final Senate passage later this week of a package of amendments to the landmark bill both chambers already have passed:

Health Care Reform Bill Summary: A Look At What's in the Bill

Posted: Monday, March 22, 2010

The bill has passed the House and is ready for President Obama's signature. Here's a brief look at what's in it.

High Cholesterol, Diabetes Lead Drug Spending for the Elderly

Posted: Sunday, March 21, 2010

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 -- about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers.

The White House Blog: Voices of Reform

Posted: Wednesday, March 17, 2010

There’s no issue that touches people more directly than health care, so there’s good reason for people to want as much reassurance as they can get before the country goes ahead with reform. That’s why those who work in our health care system day in and day out have a unique role in weighing in on the merits of any reform effort.

In an unprecedented show of diverse, even sweeping support, a virtual army of organizations came out in support of the President’s health reform proposal this morning as Congress prepares to make its final decisions.

Special Newsflash: Exenatide Once Weekly -- FDA Update

Posted: Tuesday, March 16, 2010

Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).

In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests raised in the letter primarily relate to the finalization of the product labeling with accompanying Risk Evaluation and Mitigation Strategy (REMS) and clarification of existing manufacturing processes.

Unhealthy Foods Become Less Popular with Increasing Costs -- JAMA

Posted: Sunday, March 14, 2010

Adults tend to eat less pizza and drink less soda as the price of these items increases, and their body weight and overall calorie intake also appear to decrease, according to a new report.

FDA Reports 17 Food Companies Have Misleading Product Labels

Posted: Sunday, March 14, 2010

The FDA warned 17 food makers -- including POM and Nestle -- that their "misleading" product labels violate federal law. The warning letters say the firms face having their products pulled from grocery shelves if they don't make changes.

Ninety-two Percent of Pre-Diabetes Patients Are Unaware of their Status

Posted: Sunday, March 14, 2010

Most people are not aware whether they are pre-diabetic and most who know they are, are not doing anything about it, say U.S. health officials. And from the ARIC study, those with prediabetes are found to be at risk for cardiovascular disease with an A1c above 5%.

Lasting Benefit Seen for Lifestyle Changes, Metformin in Diabetes

Posted: Sunday, February 28, 2010

For people at risk for Type 2 diabetes, a combination of diet, exercise and, to a lesser extent, treatment with metformin can help keep the disease at bay for 10 years, researchers said.

LifeScan Recalls Specific Lots of Consumer and Professional OneTouch® SureStep® Test Strips Due To Inaccurate Readings at High Levels

Posted: Friday, February 26, 2010

LifeScan, Inc. is conducting a voluntary recall in the United States of eight lots of OneTouch® SureStep® Test Strips, used by people with diabetes to measure their blood glucose levels at home. The test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL.